PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim r ...
Oncoinvent, a clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, today announced the successful enrollment of the sixth patient into the safety lead-in ...
The shares in TGS ASA will be traded ex dividend NOK 1.73 (USD 0.155) as from today, 27 February 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results